At WindMIL Therapeutics®, our mission is to translate novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.
Founded date: 2016
Investors 5
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Medivate P... | medivatepa... |
| - | LINEA Inve... | lineainves... |
| - | Johns Hopk... | ventures.j... |
| - | Catalio Ca... | cataliocap... |
Mentions in press and media 1
| Date | Title | Description |
| 18.06.2018 | WindMIL Therapeutics Raises $32.5M In Series B | --Phase 2, multi-center randomized trial of MILs in high-risk multiple myeloma fully enrolled -- -- Financing will support upcoming clinical trials of MILs in solid tumors -- -- Preclinical work demonstrating MILs as a superior source for C... |